glutamic acid and canagliflozin

glutamic acid has been researched along with canagliflozin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Beneke, S; Delp, J; Dietrich, DR; Gutbier, S; Leist, M; Schlichenmaier, N; Secker, PF	1
Chekkal, N; Hulea, L; Palia, R; Papadopoli, D; Pollak, M; St-Pierre, J; Topisirovic, I; Uchenunu, O	1

Other Studies

2 other study(ies) available for glutamic acid and canagliflozin

Article	Year
Canagliflozin mediated dual inhibition of mitochondrial glutamate dehydrogenase and complex I: an off-target adverse effect. Cell death & disease, 2018, 02-14, Volume: 9, Issue:2 Topics: Alanine; Benzhydryl Compounds; Canagliflozin; Cell Death; Cell Line; Citric Acid Cycle; Electron Transport Complex I; Epithelial Cells; Glucosides; Glutamate Dehydrogenase; Glutamic Acid; Glutamine; Humans; Hypoglycemic Agents; Kidney Tubules, Proximal; Metabolomics; Mitochondria	2018
Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin. Neoplasia (New York, N.Y.), 2021, Volume: 23, Issue:4 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Canagliflozin; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Citric Acid Cycle; Diabetes Mellitus, Type 2; Female; Glucose; Glutamate Dehydrogenase; Glutamic Acid; Humans; MCF-7 Cells; Mice; Mitochondria; Oxygen Consumption; RNA Interference; RNA, Small Interfering; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2021

Article

Year

Canagliflozin mediated dual inhibition of mitochondrial glutamate dehydrogenase and complex I: an off-target adverse effect.

Cell death & disease, 2018, 02-14, Volume: 9, Issue:2

Topics: Alanine; Benzhydryl Compounds; Canagliflozin; Cell Death; Cell Line; Citric Acid Cycle; Electron Transport Complex I; Epithelial Cells; Glucosides; Glutamate Dehydrogenase; Glutamic Acid; Glutamine; Humans; Hypoglycemic Agents; Kidney Tubules, Proximal; Metabolomics; Mitochondria

2018

Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin.

Neoplasia (New York, N.Y.), 2021, Volume: 23, Issue:4

Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Canagliflozin; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Citric Acid Cycle; Diabetes Mellitus, Type 2; Female; Glucose; Glutamate Dehydrogenase; Glutamic Acid; Humans; MCF-7 Cells; Mice; Mitochondria; Oxygen Consumption; RNA Interference; RNA, Small Interfering; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors

2021